Interferon-α Treatment in Systemic Mastocytosis
Journal:
Current Drug Targets
Volume:
12
Page:
433-436
Author(s):
Ole Weis Bjerrum
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
239-253
Author(s):
D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
285-295
Author(s):
D. J. Kuhn, R. Z. Orlowski and C. C. Bjorklund
Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Journal:
Current Molecular Medicine
Volume:
11
Page:
140-151
Author(s):
C. Fan, B. K. Foster, W. H. Wallace and C. J. Xian
Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1100-1121
Author(s):
D. Delmas, E. Solary and N. Latruffe
Clinical Pharmacogenetics of Methotrexate
Journal:
Current Drug Metabolism
Volume:
12
Page:
278-286
Author(s):
Pasqualina Castaldo, Simona Magi, Annamaria Assunta Nasti, Sara Arcangeli, Vincenzo Lariccia, Nicola Alesi, Massimo Tocchini and Salvatore Amoroso
Current Technological Development of Antibody Therapeutics
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
11
Page:
21-32
Author(s):
Ayami Yamaguchi, Katsuaki Usami and Kazuhiro Masuda
TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
11
Page:
54-67
Author(s):
Giorgio Santoni and Valerio Farfariello
HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
11
Page:
76-89
Author(s):
Wei-Hua Yan